We are live on
!
Find out more
HCA
Harbor Capital Advisors Portfolio holdings
AUM
$1.47B
1-Year Est. Return
42.58%
This Fund
S&P 500
This Quarter
Est. Return
+1.8%
1 Year Est. Return
+42.58%
3 Year Est. Return
+118.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$275M
AUM Growth
–
Cap. Flow
+$290M
Cap. Flow
% of AUM
105.54%
Top 10 Holdings %
Top 10 Hldgs %
32.71%
Holding
92
New
92
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$13M |
| 2 |
Tesla
TSLA
|
+$10.1M |
| 3 |
Lam Research
LRCX
|
+$9.32M |
| 4 |
Amazon
AMZN
|
+$9.22M |
| 5 |
Salesforce
CRM
|
+$8.67M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 48.21% |
| 2 | Consumer Discretionary | 18.52% |
| 3 | Healthcare | 17.22% |
| 4 | Communication Services | 9.83% |
| 5 | Financials | 2.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arrowhead Research
ARWR
$12.6B
| $1.68M | 0.61% |
+25,358
| New | +$1.74M |
|
52
Arvinas
ARVN
$587M
| $1.61M | 0.59% |
+19,633
| New | +$1.6M |
|
|
CTLT
53
DELISTED
CATALENT, INC.
CTLT
| $1.6M | 0.58% |
+12,522
| New | +$1.61M |
|
54
Insulet
PODD
$10B
| $1.57M | 0.57% |
+5,905
| New | +$1.71M |
|
|
ZEN
55
DELISTED
ZENDESK INC
ZEN
| $1.56M | 0.57% |
+14,943
| New | +$1.6M |
|
|
BPMC
56
DELISTED
Blueprint Medicines
BPMC
| $1.53M | 0.56% |
+14,314
| New | +$1.5M |
|
57
Ironwood Pharmaceuticals
IRWD
$709M
| $1.42M | 0.52% |
+121,318
| New | +$1.49M |
|
|
AMED
58
DELISTED
Amedisys
AMED
| $1.38M | 0.5% |
+8,532
| New | +$1.37M |
|
59
DexCom
DXCM
$33.8B
| $1.35M | 0.49% |
+10,096
| New | +$1.45M |
|
|
RNAM
60
DELISTED
Avidity Biosciences
RNAM
| $1.35M | 0.49% |
+56,648
| New | +$1.35M |
|
|
SIVB
61
DELISTED
SVB Financial Group
SIVB
| $1.32M | 0.48% |
+1,949
| New | +$1.37M |
|
62
Krystal Biotech
KRYS
$9.67B
| $1.29M | 0.47% |
+18,472
| New | +$1.08M |
|
63
Regenxbio
RGNX
$704M
| $1.25M | 0.46% |
+38,253
| New | +$1.3M |
|
|
GTM
64
ZoomInfo Technologies
GTM
$1.18B
| $1.25M | 0.45% |
+19,399
| New | +$1.3M |
|
65
Cooper Companies
COO
$15B
| $1.2M | 0.44% |
+11,476
| New | +$1.17M |
|
66
Idexx Laboratories
IDXX
$46.2B
| $1.16M | 0.42% |
+1,758
| New | +$1.1M |
|
67
Bio-Rad Laboratories Class A
BIO
$9.53B
| $1.14M | 0.42% |
+1,510
| New | +$1.13M |
|
|
AUTL
68
Autolus Therapeutics
AUTL
$623M
| $1.1M | 0.4% |
+211,319
| New | +$1.27M |
|
69
Kymera Therapeutics
KYMR
$9.11B
| $1.07M | 0.39% |
+16,851
| New | +$981K |
|
|
MASI
70
DELISTED
Masimo
MASI
| $1.07M | 0.39% |
+3,652
| New | +$1.04M |
|
|
SYBX
71
DELISTED
Synlogic
SYBX
| $1.06M | 0.39% |
+29,170
| New | +$1.13M |
|
72
Lightspeed Commerce
LSPD
$1.36B
| $1.03M | 0.37% |
+25,439
| New | +$1.74M |
|
73
Zscaler
ZS
$28.9B
| $1.01M | 0.37% |
+3,158
| New | +$994K |
|
74
Replimune Group
REPL
$1.15B
| $1.01M | 0.37% |
+37,105
| New | +$1.11M |
|
75
Iovance Biotherapeutics
IOVA
$2.94B
| $984K | 0.36% |
+51,540
| New | +$1.13M |
|
Similar funds
KRSITF
SRC
ACM
LLL
SWA
L7C
HTI
CHAM
Harbor Capital Advisors's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Harbor Capital Advisors, which disclosed 92 positions worth $275M. Its ten largest holdings account for 33% of the portfolio.
Its largest position is Microsoft: 39,952 shares worth $13.4M.
By sector, the portfolio is most concentrated in Technology at 48% of assets, followed by Consumer Discretionary and Healthcare.
- Harbor Capital Advisors's largest Q4 2021 buy was Microsoft: 39,952 shares worth $13.4M.
- Harbor Capital Advisors's ten largest holdings make up 33% of its $275M portfolio in Q4 2021.
- Harbor Capital Advisors disclosed 92 positions in Q4 2021, its first 13F filing on record.
Based on Harbor Capital Advisors's 13F filing for Q4 2021, filed 4 Feb 2022.